[Myocardial infarction after influenza vaccination]

Area of Science:

• Immunology
• Cardiology
• Public Health

Background:

• Influenza vaccination is a routine public health measure to prevent seasonal influenza.
• Vaccines are typically well-tolerated, with common side effects including mild fever and myalgia.
• Rarely, more severe adverse events have been associated with influenza vaccination.

Observation:

• A case report of a female patient experiencing secondary vasculitis and myocardial infarction following influenza vaccination.
• The patient presented with symptoms indicative of a severe systemic reaction post-immunization.
• The patient was treated with cortisol and demonstrated recovery.

Findings:

• Systemic vasculitis is a rare but documented potential adverse event following influenza vaccination.
• Myocardial infarction can occur in conjunction with post-vaccination vasculitis.
• Early recognition and appropriate treatment, such as corticosteroid therapy, are crucial for managing these rare events.

Implications:

• This case underscores the importance of monitoring for rare adverse events after influenza vaccination, particularly in patients with pre-existing cardiovascular conditions.
• Further research into the mechanisms underlying vaccine-associated vasculitis is warranted.
• Recommendations for influenza vaccination in patients with coronary artery disease should consider the potential for rare, severe adverse reactions.